Health Catalyst Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-118.15	-137.4	-153.21	-115.02	-240.92	-114.02	-58.78
Depreciation & Amortization	45.21	51.53	41.11	23.03	12.67	10.42	5.89
Share-Based Compensation	55.76	72.1	65.15	37.96	17.84	4.2	4.24
Other Operating Activities	-15.9	-21.5	23.83	27.88	-2.6	7.08	0.07
Operating Cash Flow	-33.08	-35.27	-23.12	-26.15	-32.18	-40.3	-36.83
Capital Expenditures	-13.16	-15.13	-17.07	-9.2	-2.34	-2.25	-2.42
Acquisitions	-11.39	-27.85	-46.76	-101.66	0	0	0
Change in Investments	45.97	6.21	-74.47	29.54	-205.33	23.88	25.71
Other Investing Activities	-1.12	-2.26	-1.37	-1.25	-1.94	-0.23	-0.88
Investing Cash Flow	20.29	-39.02	-139.68	-82.57	-209.6	21.4	22.41
Share Issuance / Repurchase	2.73	-1.27	270.37	40.54	200.28	-5.67	0.08
Debt Issued / Paid	0	0	0	143.7	25.35	9.95	9.79
Other Financing Activities	-	-1.34	-6.29	-1.62	5.75	20.06	15.01
Financing Cash Flow	2.73	-2.61	264.08	182.61	231.38	24.35	24.87
Exchange Rate Effect	0.02	-0.01	-0.01	0.03	0.01	0	0
Net Cash Flow	-10.04	-76.92	101.27	73.92	-10.4	5.45	10.45
Free Cash Flow	-46.24	-50.4	-40.2	-35.35	-34.52	-42.54	-39.25
Free Cash Flow Margin	-15.63%	-18.24%	-16.61%	-18.72%	-22.28%	-37.79%	-53.70%
Free Cash Flow Per Share	-0.82	-0.94	-0.85	-0.89	-1.84	-8.87	-8.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).